FRED GROSSMAN
Glenmark Pharma begins clinical trial of anti-myeloma drugThe additional study objectives include assessment of biomarkers, immunogenicity and additional measures of anti- tumour activity, it added.08 Dec, 2017, 11.39 AM IST
Glenmark Pharma releases investigational skin findingsGlenmark Pharma President and Chief Medical Officer Fred Grossman said atopic dermatitis can have a severe impact on quality of life and th...01 Aug, 2017, 12.13 PM IST
Load More